Mr Weaver is primarily responsible for management of the financial operations of the company. Most recently, Mr Weaver served as CFO of Talyst, a pharmacy automation healthcare IT company from 2007 to December 2008.
Mr Weaver is a certified public accountant and received his MBA in finance from Boston College and his BS in accounting from Trinity University.
Jerry McMahon, chairman and CEO of Poniard, said: “Greg has been a key executive in innovative and successful publicly traded healthcare companies, and has played a crucial role in increasing value for shareholders. His financial management experience will be invaluable as we move forward to complete enrollment in our pivotal phase III trial of picoplatin in small cell lung cancer and to develop strategic partnering and other opportunities to support our commercialization strategy.”